<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Cantor Fitzgerald senior biotech analyst Alethia Young joins ‘Closing Bell’ to discuss the FDA approval for Biogen’s Alzheimer’s drug, calling this “one of the biggest approvals in biotech’s history.”
...read full article on CNBC Television
